155 related articles for article (PubMed ID: 35796638)
1. Microneedle delivery of botulinum toxin type A combined with hyaluronic acid for the synergetic management of multiple sternal keloids with oily skin: A retrospective clinical investigation.
Zhang S; Peng Y; Fan H; Zhang Y; Min P
J Cosmet Dermatol; 2022 Nov; 21(11):5601-5609. PubMed ID: 35796638
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A versus 5-Fluorouracil in treatment of keloid.
Ismail SA; Mohammed NHK; Sotohy M; Abou-Taleb DAE
Arch Dermatol Res; 2021 Sep; 313(7):549-556. PubMed ID: 32892246
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and possible mechanisms of botulinum toxin treatment of oily skin.
Shuo L; Ting Y; KeLun W; Rui Z; Rui Z; Hang W
J Cosmet Dermatol; 2019 Apr; 18(2):451-457. PubMed ID: 30697928
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Efficacy of Corticosteroid and Corticosteroid Combined with Botulinum Toxin Type A in the Treatment of Keloid and Hypertrophic Scars: A Meta-Analysis.
Liu XG; Zhang D
Aesthetic Plast Surg; 2021 Dec; 45(6):3037-3044. PubMed ID: 34184094
[TBL] [Abstract][Full Text] [Related]
5. Intralesional Injection of Botulinum Toxin Type A Compared with Intralesional Injection of Corticosteroid for the Treatment of Hypertrophic Scar and Keloid: A Systematic Review and Meta-Analysis.
Bi M; Sun P; Li D; Dong Z; Chen Z
Med Sci Monit; 2019 Apr; 25():2950-2958. PubMed ID: 31006769
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin.
Rose AE; Goldberg DJ
Dermatol Surg; 2013 Mar; 39(3 Pt 1):443-8. PubMed ID: 23293895
[TBL] [Abstract][Full Text] [Related]
7. Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: Clinical and pathological study.
Khatery BHM; Hussein HA; Abd-El-Raheem TA; El Hanbuli HM; Yassen NN
Dermatol Ther; 2022 Oct; 35(10):e15748. PubMed ID: 36190006
[TBL] [Abstract][Full Text] [Related]
8. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial.
Shaarawy E; Hegazy RA; Abdel Hay RM
J Cosmet Dermatol; 2015 Jun; 14(2):161-6. PubMed ID: 25810045
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of IPL device combined with intralesional corticosteroid injection for the treatment of keloids and hypertrophic scars with regards to the recovery of skin barrier function: A pilot study.
Kim DY; Park HS; Yoon HS; Cho S
J Dermatolog Treat; 2015 Oct; 26(5):481-4. PubMed ID: 25816122
[TBL] [Abstract][Full Text] [Related]
10. Laser-assisted topical corticosteroid delivery for the treatment of keloids.
Park JH; Chun JY; Lee JH
Lasers Med Sci; 2017 Apr; 32(3):601-608. PubMed ID: 28124198
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Botulinum Toxin A in Preventing Recurrence Keloids: Double Blinded Randomized Controlled Trial Study: Intraindividual Subject.
Pruksapong C; Yingtaweesittikul S; Burusapat C
J Med Assoc Thai; 2017 Mar; 100(3):280-6. PubMed ID: 29911784
[TBL] [Abstract][Full Text] [Related]
12. Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses Into Clinical Practice.
Fabi SG; Park JY; Goldie K; Wu W
Aesthet Surg J; 2023 Aug; 43(9):1015-1024. PubMed ID: 36857534
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin and platelet rich plasma as innovative therapeutic modalities for keloids.
Neinaa YME; Elsayed TA; Mohamed DA; Elfar NN
Dermatol Ther; 2021 May; 34(3):e14900. PubMed ID: 33605002
[TBL] [Abstract][Full Text] [Related]
14. Assessment of laser-assisted delivery vs intralesional injection of botulinum toxin A in treatment of hypertrophic scars and keloids.
Sabry HH; Ibrahim EA; Hamed AM
Dermatol Ther; 2020 Nov; 33(6):e13980. PubMed ID: 32638463
[TBL] [Abstract][Full Text] [Related]
15. Intradermal Botulinum Toxin A Injection for Scalp Sebum Secretion Regulation: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Prospective Study in Chinese Subjects.
Li Y; Chen X; Luo X; Li L; Lin Y
Aesthet Surg J; 2023 Jan; 43(1):NP38-NP48. PubMed ID: 36004504
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions.
Gamil HD; Khattab FM; El Fawal MM; Eldeeb SE
J Dermatolog Treat; 2020 Aug; 31(5):535-544. PubMed ID: 31184533
[No Abstract] [Full Text] [Related]
17. Potentials for implementing pressure-controlled jet injection in management of keloids with intralesional 5FU and corticosteroids.
Levenberg A; Vinshtok Y; Artzi O
J Cosmet Dermatol; 2020 Aug; 19(8):1966-1972. PubMed ID: 32603031
[TBL] [Abstract][Full Text] [Related]
18. [A multicenter prospective randomized controlled clinical study of 5-fluorouracil in different mass concentrations combined with triamcinolone in the treatment of keloids].
Lin N; Li M; Guo ZH; Wu MQ; Zhou YK; Zhang LX; Yu H; Zhong Y; Huang CS
Zhonghua Shao Shang Za Zhi; 2021 May; 37(5):437-445. PubMed ID: 34044526
[No Abstract] [Full Text] [Related]
19. Association Between Sebum, Total Cholesterol, and Low-Density Lipoprotein (LDL) Cholesterol Levels With Post-acne Keloids.
Kurniawati Y; Rodian MS; Argentina F; Prasasty GD; Dalilah D; Nathania A
Cureus; 2023 Aug; 15(8):e43096. PubMed ID: 37692568
[TBL] [Abstract][Full Text] [Related]
20. Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: A Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation.
Min P; Xi W; Grassetti L; Trisliana Perdanasari A; Torresetti M; Feng S; Su W; Pu Z; Zhang Y; Han S; Zhang YX; Di Benedetto G; Lazzeri D
Aesthet Surg J; 2015 Jul; 35(5):600-10. PubMed ID: 25825422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
